MENU
NTLA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Intellia Therapeutics (NTLA) Earnings Date & Reports
Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
NTLA is expected to report earnings to rise 2.50% to -81 cents per share on November 05
Q3'26
Est.
$-0.82
Q2'26
Est.
$-0.80
Q1'26
Beat
by $0.10
Q4'25
Beat
by $0.13
Q3'25
Beat
by $0.09
The last earnings report on August 06 showed earnings per share of -80 cents, meeting the estimate of -80 cents. With 2.32M shares outstanding, the current market capitalization sits at 1.63B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
What’s So Special about an IRA?
What should I look for in a good Investment Performance Evaluation calculator?
Who Are the Titans of U.S. Stock Brokerage?A Deep Dive into the Industry's Leading Firms.
What Is Interest and How Does It Impact Financial Transactions?
Tickeron Launches New Price Action Trading Bots for High and Medium Volatility Stocks
A.I. Advisor
published General Information
General Information
a developer of proprietary, potentially curative therapeutics
Industry Biotechnology
Industry
Biotechnology
Address
40 Erie Street
Phone
+1 857 285-6200
Employees
377
Web
https://www.intelliatx.com